nifedipine has been researched along with Cancer of the Thyroid in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raue, F | 1 |
| Serve, H | 1 |
| Grauer, A | 1 |
| Rix, E | 1 |
| Scherübl, H | 1 |
| Schneider, HG | 1 |
| Ziegler, R | 1 |
| Nakamura, A | 1 |
| Kakudo, K | 1 |
| Watanabe, K | 1 |
| Satoh, R | 1 |
| Shimaoka, K | 1 |
2 other studies available for nifedipine and Cancer of the Thyroid
| Article | Year |
|---|---|
Role of voltage-dependent calcium channels in secretion of calcitonin from human medullary thyroid carcinoma cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Morphological changes of human thyroid medullary carcinoma cell line treated with calcium channel antagonist nifedipine.
Topics: Calcitonin; Carcinoma; Cytoplasmic Granules; Humans; Nifedipine; Thyroid Neoplasms; Tumor Cells, Cul | 1988 |